phosphotyrosine has been researched along with Bone Cancer in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alho, I; Bicho, M; Coelho, C; Costa, L | 1 |
| He, M; Jiang, L; Ren, Z; Wang, G; Wang, J | 1 |
| Baskaran, R; Chiang, GG; Wang, JY | 1 |
| Gutkind, JS; Sanchez-Arevalo, VJ; Sanchez-Prieto, R; Servitja, JM | 1 |
4 other study(ies) available for phosphotyrosine and Bone Cancer
| Article | Year |
|---|---|
Low Molecular Weight Protein Tyrosine Phosphatase Slow Isoform Knockdown in MDA-MB-435 Cells Decreases RAW 264.7 Osteoclastic Differentiation.
Topics: Adenocarcinoma; Animals; Bone Neoplasms; Breast Neoplasms; Cell Differentiation; Cell Line, Tumor; Culture Media, Conditioned; Interleukin-6; Interleukin-8; Mice; Neoplasm Proteins; Osteoclasts; Phosphorylation; Phosphotyrosine; Protein Isoforms; Protein Processing, Post-Translational; Protein Tyrosine Phosphatases; Proto-Oncogene Proteins; RANK Ligand; RAW 264.7 Cells; RNA Interference; RNA, Small Interfering; src-Family Kinases | 2016 |
Noscapine targets EGFR
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; ErbB Receptors; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Molecular Targeted Therapy; Neoplasm Invasiveness; Neoplasm Proteins; Noscapine; Osteosarcoma; Papaver; Phosphorylation; Phosphotyrosine; Protein Kinase Inhibitors; Protein Processing, Post-Translational; RNA Interference; RNA, Small Interfering; Signal Transduction; Xenograft Model Antitumor Assays | 2016 |
Identification of a binding site in c-Ab1 tyrosine kinase for the C-terminal repeated domain of RNA polymerase II.
Topics: Amino Acid Sequence; Animals; Binding Sites; Binding, Competitive; Bone Neoplasms; Cell Line; Chlorocebus aethiops; Consensus Sequence; Genes, abl; Glutathione Transferase; Humans; Kidney; Kinetics; Molecular Sequence Data; Mutagenesis, Site-Directed; Osteosarcoma; Phosphorylation; Phosphotyrosine; Protein-Tyrosine Kinases; Proto-Oncogene Mas; Proto-Oncogene Proteins c-abl; Recombinant Fusion Proteins; RNA Polymerase II; Sequence Deletion; Transcription, Genetic; Transfection; Tumor Cells, Cultured | 1996 |
Regulation of p73 by c-Abl through the p38 MAP kinase pathway.
Topics: Bone Neoplasms; Calcium-Calmodulin-Dependent Protein Kinases; Cell Line; DNA-Binding Proteins; Enzyme Activation; Enzyme Inhibitors; Epithelial Cells; Genes, abl; Genes, Tumor Suppressor; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Kidney; MAP Kinase Kinase 1; MAP Kinase Kinase 6; MAP Kinase Kinase 7; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Multigene Family; Nuclear Proteins; Osteosarcoma; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Phosphoserine; Phosphotyrosine; Proline; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-abl; Pyridines; Recombinant Fusion Proteins; src Homology Domains; Transcription, Genetic; Transfection; Tumor Cells, Cultured; Tumor Protein p73; Tumor Suppressor Proteins | 2002 |